A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs
Condition: Rheumatoid Arthritis Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARDs Sponsor: Hoffmann-La Roche Not yet recruiting - verified July 2011